These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 11417444

  • 21. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q, Cao Q.
    Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
    [Abstract] [Full Text] [Related]

  • 22. A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations.
    Coulthard SA, Rabello C, Robson J, Howell C, Minto L, Middleton PG, Gandhi MK, Jackson G, McLelland J, O'Brien H, Smith S, Reid MM, Pearson AD, Hall AG.
    Br J Haematol; 2000 Sep; 110(3):599-604. PubMed ID: 10997970
    [Abstract] [Full Text] [Related]

  • 23. Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.
    Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C.
    J Am Soc Nephrol; 2001 Jan; 12(1):170-176. PubMed ID: 11134264
    [Abstract] [Full Text] [Related]

  • 24. Monitoring of TPMT in heart transplant recipients under immunosuppressive therapy with azathioprine.
    Gummert JF, Schütz E, Oellerich M, Mohr FW, Dalichau H.
    Artif Organs; 1995 Sep; 19(9):918-20. PubMed ID: 8687298
    [Abstract] [Full Text] [Related]

  • 25. Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.
    Hessels AC, Rutgers A, Sanders JSF, Stegeman CA.
    PLoS One; 2018 Sep; 13(4):e0195524. PubMed ID: 29630648
    [Abstract] [Full Text] [Related]

  • 26. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
    Naughton MA, Battaglia E, O'Brien S, Walport MJ, Botto M.
    Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
    [Abstract] [Full Text] [Related]

  • 27. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
    Karim H, Appell ML, Fotoohi A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov 15; 939():80-5. PubMed ID: 24113235
    [Abstract] [Full Text] [Related]

  • 28. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
    Citterio-Quentin A, Moulsma M, Gustin MP, Boulieu R.
    Ther Drug Monit; 2017 Oct 15; 39(5):483-491. PubMed ID: 28650902
    [Abstract] [Full Text] [Related]

  • 29. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
    Ansari A, Hassan C, Duley J, Marinaki A, Shobowale-Bakre EM, Seed P, Meenan J, Yim A, Sanderson J.
    Aliment Pharmacol Ther; 2002 Oct 15; 16(10):1743-50. PubMed ID: 12269967
    [Abstract] [Full Text] [Related]

  • 30. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M.
    Acta Pol Pharm; 2012 Oct 15; 69(3):405-10. PubMed ID: 22594254
    [Abstract] [Full Text] [Related]

  • 31. Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
    Sebbag L, Boucher P, Davelu P, Boissonnat P, Champsaur G, Ninet J, Dureau G, Obadia JF, Vallon JJ, Delaye J.
    Transplantation; 2000 Apr 15; 69(7):1524-7. PubMed ID: 10798786
    [Abstract] [Full Text] [Related]

  • 32. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
    Boonsrirat U, Angsuthum S, Vannaprasaht S, Kongpunvijit J, Hirankarn N, Tassaneeyakul W, Avihingsanon Y.
    Lupus; 2008 Feb 15; 17(2):132-4. PubMed ID: 18250137
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism.
    Lennard L, Van Loon JA, Weinshilboum RM.
    Clin Pharmacol Ther; 1989 Aug 15; 46(2):149-54. PubMed ID: 2758725
    [Abstract] [Full Text] [Related]

  • 35. Thiopurine methyltransferase activity and efficacy of azathioprine immunosuppression in transplant recipients.
    Chocair PR, Duley JA, Simmonds HA, Cameron JS.
    Adv Exp Med Biol; 1991 Aug 15; 309A():61-4. PubMed ID: 1789271
    [No Abstract] [Full Text] [Related]

  • 36. Whose TPMT activity is it anyway?
    Ford L, Prout C, Gaffney D, Berg J.
    Ann Clin Biochem; 2004 Nov 15; 41(Pt 6):498-500. PubMed ID: 15588444
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW.
    Clin Gastroenterol Hepatol; 2006 Jan 15; 4(1):44-9. PubMed ID: 16431304
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.